{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:22:40Z","timestamp":1760548960631},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,5]],"date-time":"2010-06-05T00:00:00Z","timestamp":1275696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00464-010-1125-8","type":"journal-article","created":{"date-parts":[[2010,6,4]],"date-time":"2010-06-04T15:39:15Z","timestamp":1275665955000},"page":"305-308","source":"Crossref","is-referenced-by-count":24,"title":["Technical feasibility of laparoscopic total mesorectal excision for patients with low rectal cancer after concurrent radiation and chemotherapy with bevacizumab plus FOLFOX"],"prefix":"10.1007","volume":"25","author":[{"given":"Jin-Tung","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Shiee","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,5]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1634\/theoncologist.2008-0213","volume":"14","author":"HI Hurwitz","year":"2009","unstructured":"Hurwitz HI, Yi J, Ince W, Novotny WF, Rosen O (2009) The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of k-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer. Oncologist 14:22\u201328","journal-title":"Oncologist"},{"key":"1125_CR2","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.2007.13.7679","volume":"26","author":"B Gruenberger","year":"2008","unstructured":"Gruenberger B, Tamandl D, Schueller J, Scheithauer W, Zielinski C, Herbst F, Gruenberger T (2008) Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 26:1830\u20131835","journal-title":"J Clin Oncol"},{"key":"1125_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cncr.23516","volume":"113","author":"HM Quah","year":"2008","unstructured":"Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR (2008) Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 113:57\u201364","journal-title":"Cancer"},{"key":"1125_CR4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","volume":"10","author":"CG Willett","year":"2004","unstructured":"Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145\u2013147","journal-title":"Nat Med"},{"key":"1125_CR5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncponc0813","volume":"4","author":"CG Willett","year":"2007","unstructured":"Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA, Jain RK (2007) Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol 4:316\u2013321","journal-title":"Nat Clin Pract Oncol"},{"key":"1125_CR6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10350-005-0325-0","volume":"49","author":"JT Liang","year":"2006","unstructured":"Liang JT, Lai HS, Lee PH (2006) Laparoscopic total mesorectal excision for rectal cancer. Dis Colon Rectum 49:517\u2013518","journal-title":"Dis Colon Rectum"},{"key":"1125_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1245\/s10434-006-9135-4","volume":"14","author":"JT Liang","year":"2007","unstructured":"Liang JT, Huang KC, Lai HS, Lee PH, Jeng YM (2007) Oncologic results of laparoscopic versus conventional open surgery for stage II or III left-sided colon cancers: a randomized controlled trial. Ann Surg Oncol 14:109\u2013117","journal-title":"Ann Surg Oncol"},{"key":"1125_CR8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bjs.1800691019","volume":"69","author":"RJ Heald","year":"1982","unstructured":"Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg 69:613\u2013616","journal-title":"Br J Surg"},{"key":"1125_CR9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10350-005-0250-2","volume":"49","author":"JT Liang","year":"2006","unstructured":"Liang JT, Lai HS, Lee PH (2006) Laparoscopic abdominoanal pull-through procedure for male patients with lower rectal cancer after chemoradiation therapy. Dis Colon Rectum 49:259\u2013260","journal-title":"Dis Colon Rectum"},{"key":"1125_CR10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00464-005-0460-7","volume":"20","author":"JT Liang","year":"2006","unstructured":"Liang JT, Lai HS, Lee PH (2006) Laparoscopic abdominoperineal resection for lower rectal cancers: how we do it? Surg Endosc 20:695\u2013696","journal-title":"Surg Endosc"},{"key":"1125_CR11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ejso.2008.01.001","volume":"34","author":"S Kandutsch","year":"2008","unstructured":"Kandutsch S, Klinger M, Hacker S, Wrba F, Gruenberger B, Gruenberger T (2008) Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. EJSO 34:1231\u20131236","journal-title":"EJSO"},{"key":"1125_CR12","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","volume":"23","author":"C R\u00f6del","year":"2005","unstructured":"R\u00f6del C, Martus P, Papadoupolos T, F\u00fczesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C (2005) Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23:8688\u20138696","journal-title":"J Clin Oncol"},{"key":"1125_CR13","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC, EORTC Radiotherapy Group Trial 22921 (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114\u20131123","journal-title":"N Engl J Med"},{"key":"1125_CR14","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1056\/NEJMoa032651","volume":"350","author":"Clinical Outcomes of Surgical Therapy Study Group","year":"2004","unstructured":"Clinical Outcomes of Surgical Therapy Study Group (2004) A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350:2050\u20132059","journal-title":"N Engl J Med"},{"key":"1125_CR15","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1245\/s10434-009-0603-5","volume":"16","author":"JT Poon","year":"2009","unstructured":"Poon JT, Law WL (2009) Laparoscopic resection for rectal cancer: a review. Ann Surg Oncol 16:3038\u20133047","journal-title":"Ann Surg Oncol"},{"key":"1125_CR16","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1200\/JCO.2006.05.6754","volume":"24","author":"DP Ryan","year":"2006","unstructured":"Ryan DP, Niedzwiecki D, Hollis D, Mediema BE, Wadler S, Tepper JE, Goldberg RM, Mayer RJ, Cancer and Leukemia Group B 89901 (2006) Phase I\/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: cancer and leukemia group B 89901. J Clin Oncol 24:2557\u20132562","journal-title":"J Clin Oncol"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-010-1125-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00464-010-1125-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-010-1125-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:56:59Z","timestamp":1559073419000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00464-010-1125-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,5]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1007\/s00464-010-1125-8","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,5]]}}}